Skip to main navigation
Skip to search
Skip to main content
WashU Medicine Research Profiles Home
Help & FAQ
Home
Profiles
Departments, Divisions and Centers
Research output
Search by expertise, name or affiliation
Systemic mastocytosis, version 2.2019 clinical practice guidelines in oncology
Jason Gotlib
, Aaron T. Gerds
, Prithviraj Bose
, Mariana C. Castells
, Michael W. Deininger
, Ivana Gojo
, Krishna Gundabolu
, Gabriela Hobbs
, Catriona Jamieson
, Brandon McMahon
, Sanjay R. Mohan
, Vivian Oehler
,
Stephen Oh
, Eric Padron
, Philip Pancari
, Nikolaos Papadantonakis
, Animesh Pardanani
, Nikolai Podoltsev
, Raajit Rampal
, Erik Ranheim
Lindsay Rein, David S. Snyder, Brady L. Stein, Moshe Talpaz, Swapna Thota, Martha Wadleigh, Katherine Walsh, Mary Anne Bergman, Hema Sundar
Show 9 others
Show less
Division of Hematology
Roy and Diana Vagelos Division of Biology & Biomedical Sciences (DBBS)
Institute of Clinical and Translational Sciences (ICTS)
Siteman Cancer Center
Bursky Center for Human Immunology & Immunotherapy Programs (CHiiPs)
Department of Medicine
Rheumatic Diseases Research Resource-Based Center
DBBS - Molecular Cell Biology
DBBS - Immunology
DBBS - Molecular Genetics and Genomics
DBBS - Cancer Biology
Research output
:
Contribution to journal
›
Article
›
peer-review
48
Scopus citations
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Systemic mastocytosis, version 2.2019 clinical practice guidelines in oncology'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
Clinical Practice Guidelines
100%
Oncology
100%
Systemic Mastocytosis
100%
Extracutaneous
50%
Mastocytosis
50%
Mast Cells
25%
Patient Management
25%
Novel Targeted Therapy
25%
Clonal Proliferation
25%
Clinical Care
25%
NCCN Guidelines
25%
Most Common Form
25%
KIT mutation
25%
Heterogeneous Disorder
25%
Skin Involvement
25%
Present Challenges
25%
Mast Cell Infiltration
25%
Medicine and Dentistry
Oncology
100%
Systemic Mastocytosis
100%
Mast Cell
50%
Mastocytosis
50%
Cellular Infiltration
25%
Targeted Therapy
25%
Mediator
25%
Disease
25%